|
CAP
|
CAP + PPE
|
p value
|
---|
Characterisics
|
n
a
|
%
|
n
|
%
| |
Overall
|
24
|
46
|
28
|
54
| |
Gender
| | | | | |
Male
|
18
|
75
|
12
|
43
|
0.025
|
Age
| | | | | |
3–23 months
|
6
|
25
|
6
|
21
|
1
|
24–59 months
|
12
|
50
|
10
|
36
|
0.4
|
5–14 years
|
6
|
25
|
12
|
43
|
0.24
|
Vaccinated with
| | | | | |
PCV-7b
|
8
|
33
|
15
|
54
|
0.17
|
Hib
|
1
|
88
|
24
|
86
|
1
|
Therapy before admission
| | | | | |
NSAIDc
|
16
|
67
|
22
|
79
|
0.4
|
Antibiotic
|
7
|
29
|
15
|
54
|
0.09
|
Median duration of hospitalisation (days)
|
3
| |
15
| |
< 0.01
|
Number of patients treated by oxygen therapy
|
4
|
17
|
22
|
79
|
< 0.001
|
Median duration of symptoms before admission (days)
|
3
| |
7
| |
0.0065
|
- an = total number.
- bPCV-7 = heptavalent pneumococcal conjugate vaccine
- cNSAID = Non-Steroidal Anti-Inflammatory Drug